Vamicamide is a bioactive compound. References: Cadranel JF, Boujenah JL, Bourlière M, Fontanges T, Pol S, Trepo C, Ouzan D. Satisfaction of patients treated for chronic hepatitis C with the peginterferon alfa-2b pen device: the VISA observational study. Gastroenterol Clin Biol. 2007 Feb;31(2):180-4. PubMed PMID: 17347628.

纯度：≥98%

CAS：97987-88-7